Single Session Class to Reduce Opioid Use in Chronic Pain

Trial ID or NCT#

NCT03950791

Status

recruiting iconRECRUITING

Purpose

Prescription opioids are one of the most commonly used treatments for chronic pain, despite limited evidence of their efficacy and high morbidity and mortality risks. The study aims to determine the efficacy of a targeted single-session psychology class in reducing opioid use among patients with chronic pain. The information gained from this study has the potential to identify patients who achieve a meaningful reduction in opioid use and inform opioid reduction strategies.

Official Title

Single Session Pain Catastrophizing Class: Efficacy & Mechanisms for Reducing Opioid Use Among Chronic Pain Patients

Eligibility Criteria

Ages Eligible for Study: 18 Years to 80 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - 18-80 years of age - Diagnosis of chronic non-cancer pain (> 3 months in duration) - Currently using prescription opioids ≥ 20mg morphine equivalent daily dose (MEDD) for ≥ 3 months; - Ability and willingness to complete study procedures.
Exclusion Criteria:
  1. - Open litigation regarding a medical condition - Inability to provide informed consent and complete study procedures - Active suicidality.

Investigator(s)

Maisa Ziadni, PhD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

Contact us to find out if this trial is right for you.

Contact

Maisa Ziadni
313-725-0615